These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8737590)

  • 1. Defective hepatobiliary leukotriene elimination in patients with the Dubin-Johnson syndrome.
    Mayatepek E; Lehmann WD
    Clin Chim Acta; 1996 May; 249(1-2):37-46. PubMed ID: 8737590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of cysteinyl leukotrienes in monkey and man.
    Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D
    Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased excretion of endogenous urinary leukotriene E4 in extrahepatic cholestasis.
    Mayatepek E; Pecher G
    Clin Chim Acta; 1993 Sep; 218(2):185-92. PubMed ID: 8306442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene E4 elimination and metabolism in normal human subjects.
    Sala A; Voelkel N; Maclouf J; Murphy RC
    J Biol Chem; 1990 Dec; 265(35):21771-8. PubMed ID: 2174886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end.
    Jedlitschky G; Huber M; Völkl A; Müller M; Leier I; Müller J; Lehmann WD; Fahimi HD; Keppler D
    J Biol Chem; 1991 Dec; 266(36):24763-72. PubMed ID: 1761571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteinyl leukotrienes in the urine of patients with liver diseases.
    Uemura M; Buchholz U; Kojima H; Keppler A; Hafkemeyer P; Fukui H; Tsujii T; Keppler D
    Hepatology; 1994 Oct; 20(4 Pt 1):804-12. PubMed ID: 7927219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.
    Mayatepek E; Lehmann WD; Fauler J; Tsikas D; Frölich JC; Schutgens RB; Wanders RJ; Keppler D
    J Clin Invest; 1993 Mar; 91(3):881-8. PubMed ID: 8450067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography.
    Guhlmann A; Krauss K; Oberdorfer F; Siegel T; Scheuber PH; Müller J; Csuk-Glänzer B; Ziegler S; Ostertag H; Keppler D
    Hepatology; 1995 Jun; 21(6):1568-75. PubMed ID: 7768501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisomal leukotriene degradation: biochemical and clinical implications.
    Jedlitschky G; Mayatepek E; Keppler D
    Adv Enzyme Regul; 1993; 33():181-94. PubMed ID: 8356907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion.
    Huber M; Guhlmann A; Jansen PL; Keppler D
    Hepatology; 1987; 7(2):224-8. PubMed ID: 3030916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma.
    Asano K; Lilly CM; O'Donnell WJ; Israel E; Fischer A; Ransil BJ; Drazen JM
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):643-51. PubMed ID: 7499681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes.
    Stene DO; Murphy RC
    J Biol Chem; 1988 Feb; 263(6):2773-8. PubMed ID: 2830262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased production of cysteinyl leukotrienes in hepatorenal syndrome.
    Moore KP; Taylor GW; Maltby NH; Siegers D; Fuller RW; Dollery CT; Williams R
    J Hepatol; 1990 Sep; 11(2):263-71. PubMed ID: 2174935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dubin-Johnson syndrome: molecular basis and pathogenesis].
    Mzabi-Regaya S; Chadli-Debbiche A; Ben Brahim E; Gritli S; Goutallier-Ben Fadhel C; Khalfallah MT
    Tunis Med; 2002 Apr; 80(4):228-32. PubMed ID: 12416362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased generation of cysteinyl leukotrienes in Kawasaki disease.
    Mayatepek E; Lehmann WD
    Arch Dis Child; 1995 Jun; 72(6):526-7. PubMed ID: 7618941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical synthesis of dioxygen-18 labelled omega-/beta-oxidized cysteinyl leukotrienes: analysis by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry.
    Tsikas D; Fauler J; Frölich JC
    J Chromatogr B Biomed Appl; 1995 May; 667(2):209-21. PubMed ID: 7663693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of urinary leukotriene E4 and 16-carboxytetranordihydro leukotriene E4 excretion in allergic asthmatics after inhaled antigen.
    Tagari P; Rasmussen JB; Delorme D; Girard Y; Eriksson LO; Charleson S; Ford-Hutchinson AW
    Eicosanoids; 1990; 3(2):75-80. PubMed ID: 2169776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects.
    Maclouf J; Antoine C; De Caterina R; Sicari R; Murphy RC; Patrignani P; Loizzo S; Patrono C
    Am J Physiol; 1992 Jul; 263(1 Pt 2):H244-9. PubMed ID: 1322060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery.
    Allen SP; Sampson AP; Piper PJ; Chester AH; Ohri SK; Yacoub MH
    Coron Artery Dis; 1993 Oct; 4(10):899-904. PubMed ID: 8269196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cysteinyl leukotrienes and their metabolites in bile of patients with peroxisomal or mitochondrial beta-oxidation defects.
    Mayatepek E; Ferdinandusse S; Meissner T; Wanders RJ
    Clin Chim Acta; 2004 Jul; 345(1-2):89-92. PubMed ID: 15193981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.